---
document_datetime: 2025-01-31 08:39:42
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/kevzara-epar-all-authorised-presentations_en.pdf
document_name: kevzara-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.8584898
conversion_datetime: 2025-12-20 10:10:59.150146
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging        | Content (concentration)   | Pack size                                 |
|------------------|-------------------|------------|------------------------|---------------------------|----------------------------|---------------------------|-------------------------------------------|
| EU/1/17/1196/001 | Kevzara           | 150 mg     | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) | 1.14 ml (131.6 mg/ml)     | 2 pre-filled syringes                     |
| EU/1/17/1196/002 | Kevzara           | 150 mg     | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) | 1.14 ml (131.6 mg/ml)     | 6 (3 x 2) pre-filled syringes (multipack) |
| EU/1/17/1196/003 | Kevzara           | 200 mg     | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) | 1.14 ml (175 mg/ml)       | 2 pre-filled syringes                     |
| EU/1/17/1196/004 | Kevzara           | 200 mg     | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) | 1.14 ml (175 mg/ml)       | 6 (3 x 2) pre-filled syringes (multipack) |
| EU/1/17/1196/005 | Kevzara           | 150 mg     | Solution for injection | Subcutaneous use          | pre-filled pen (glass)     | 1.14 ml (131.6 mg/ml)     | 2 pre-filled pens                         |
| EU/1/17/1196/006 | Kevzara           | 150 mg     | Solution for injection | Subcutaneous use          | pre-filled pens (glass)    | 1.14 ml (131.6 mg/ml)     | 6 (3 x 2) pre-filled pens (multipack)     |
| EU/1/17/1196/007 | Kevzara           | 200 mg     | Solution for injection | Subcutaneous use          | pre-filled pen (glass)     | 1.14 ml (175 mg/ml)       | 2 pre-filled pens                         |
| EU/1/17/1196/008 | Kevzara           | 200 mg     | Solution for injection | Subcutaneous use          | pre-filled pens (glass)    | 1.14 ml (175 mg/ml)       | 6 (3 x 2) pre-filled pens (multipack)     |
| EU/1/17/1196/009 | Kevzara           | 150 mg     | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) | 1.14 ml (131.6 mg/ml)     | 1 pre-filled syringe                      |
| EU/1/17/1196/010 | Kevzara           | 200 mg     | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) | 1.14 ml (175 mg/ml)       | 1 pre-filled syringe                      |
| EU/1/17/1196/011 | Kevzara           | 150 mg     | Solution for injection | Subcutaneous use          | pre-filled pens (glass)    | 1.14 ml (131.6 mg/ml)     | 1 pre-filled pen                          |
| EU/1/17/1196/012 | Kevzara           | 200 mg     | Solution for injection | Subcutaneous use          | pre-filled pen (glass)     | 1.14 ml (175 mg/ml)       | 1 pre-filled pen                          |
| EU/1/17/1196/013 | Kevzara           | 175 mg/ml  | Solution for injection | Subcutaneous use          | vial (glass)               | 1.54 ml                   | 2 vials                                   |